Wex Peter, Graeter Thomas, Zaraca Francesco, Haas Victor, Decker Steffen, Bugdayev Hansanali, Ebner Heinrich
Department of Thoracic and Vascular Surgery, Clinic Loewenstein, Germany.
Thorac Surg Sci. 2009 Jul 14;6:Doc02. doi: 10.3205/tss000016.
Surgical treatment of non-small cell lung cancer (NSCLC) with aortic invasion is still debated.
Thirteen patients with locally advanced (T4) NSCLC and invasion of the descending aorta underwent pneumonectomy (n=9) or lobectomy (n=4) together with aorta en bloc resection and reconstruction (n=8) or subadventitial dissection (n=5), complete lymph node dissection, and had microscopic unsuspected node metastasis at N1 (n=5) and N2/3 (n=8) levels of whom 12 received radiation therapy. Clamp-and-sew was used to resect and reconstruct the aorta.
Operative mortality and morbidity rate was 0% and 23%, respectively. Four patients died of systemic tumor relapse and 2 of local recurrence. Six patients were alive after a median follow-up of 40 months (range 15-125 months). Overall 5-year survival rate was 45%. Median survival time and 5-year survival rate of patients after aortic resection was 35 months and 67%, respectively, and was 17 months and 0%, respectively, after aortic subadventi-tial dissection (p=0.001). N1 and N2 nodal status adversely affected survival, but survival difference was not significant (N1 versus N2/3; 52% versus 39% at 5 years; p=0.998).
Aortic resection with single station node positive T4 lung cancer can achieve long-term survival. The data indicate that aortic resection-reconstruction is associated with better outcome than subadventitial dissection.
非小细胞肺癌(NSCLC)合并主动脉侵犯的手术治疗仍存在争议。
13例局部晚期(T4)NSCLC且降主动脉受侵的患者接受了肺切除术(n = 9)或肺叶切除术(n = 4),同时进行主动脉整块切除和重建(n = 8)或外膜下剥离术(n = 5)、完整的淋巴结清扫术,其中12例患者有镜下未怀疑的N1(n = 5)和N2/3(n = 8)水平淋巴结转移,12例接受了放射治疗。采用钳夹缝合技术切除并重建主动脉。
手术死亡率和发病率分别为0%和23%。4例患者死于全身肿瘤复发,2例死于局部复发。中位随访40个月(范围15 - 125个月)后,6例患者存活。总体5年生存率为45%。主动脉切除术后患者的中位生存时间和5年生存率分别为35个月和67%,主动脉外膜下剥离术后分别为17个月和0%(p = 0.001)。N1和N2淋巴结状态对生存有不利影响,但生存差异不显著(N1与N2/3相比;5年时分别为52%和39%;p = 0.998)。
单站淋巴结阳性的T4肺癌行主动脉切除可实现长期生存。数据表明,主动脉切除重建术比外膜下剥离术预后更好。